REGULATORY AFFAIRS OUTSOURCING MARKET ANALYSIS

Regulatory Affairs Outsourcing Market, By Service Type (Regulatory Consulting and Legal Representation, Product Registration and Clinical Trial Applications, Regulatory Writing and Publishing, Regulatory Submission, Regulatory Operations, Others), By End User (Medical Device Companies, Pharmaceutical Companies, Biotechnology Companies), By Stage (Preclinical, Clinical, PMA), By Therapeutic Area (Oncology, Neurology, Cardiology, Immunology, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

In January 2023, AmerisourceBergen Corporation, drug wholesale company and a contract research organization acquired PharmaLex Holding GmbH, a leading service provider in the life sciences industry, particularly noted for its expertise in regulatory affairs. This acquisition marked a substantial expansion of AmerisourceBergen's service offerings within a critical market.
In April 2022, VCLS partnered with EC Innovations, a Chinese company specializing in global translation services. With a strong background in translating highly regulated life sciences and medical content, this collaboration significantly enhanced VCLS's capabilities and operational strengths.
In February 2021, ICON plc, Clinical research organization company completed the acquisition of PRA Health Sciences, Inc. in a transaction valued at around USD 12 billion, paid in cash and stock. This acquisition significantly bolstered ICON's capabilities in medical affairs services.
In August 2021, ProPharma Group , regulatory sciences consulting firm acquired iSafety Systems, Provider of end-to-end pharmacovigilance and safety servicesbased in India. This acquisition is anticipated to enhance ProPharma Group's global leadership in regulatory and compliance consulting, pharmacovigilance, clinical research services, and medical information.